X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,199 | -55,274 | -25,459 | 282 | -37,450 |
| Depreciation Amortization | 1,277 | 1,054 | 831 | 476 | 796 |
| Accounts receivable | 497 | 179 | -75 | 561 | -1,070 |
| Accounts payable and accrued liabilities | -2,979 | -3,621 | -967 | 2,476 | -286 |
| Other Working Capital | -2,576 | -8,094 | -7,488 | -3,280 | 2,675 |
| Other Operating Activity | -2,638 | -4,335 | -9,111 | -12,883 | -95,566 |
| Operating Cash Flow | $-85,618 | $-70,091 | $-42,269 | $-12,368 | $-130,901 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 104,674 |
| Purchase Of Investment | -63,388 | -61,487 | -16,953 | -11,888 | -57,134 |
| Sale Of Investment | 74,542 | 55,792 | 39,927 | 11,750 | 26,450 |
| Purchase Sale Intangibles | -3,000 | -3,000 | -3,000 | -3,000 | -7,000 |
| Other Investing Activity | -3,000 | -3,000 | -3,000 | -3,000 | -7,000 |
| Investing Cash Flow | $8,154 | $-8,695 | $19,974 | $-3,138 | $66,990 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 20,000 |
| Common Stock Issued | 238,628 | 92,536 | 5,631 | N/A | 294 |
| Financing Cash Flow | $238,628 | $92,536 | $5,631 | $N/A | $20,294 |
| Exchange Rate Effect | 213 | 210 | 211 | 72 | -156 |
| Beginning Cash Position | 56,475 | 56,475 | 56,475 | 56,475 | 100,248 |
| End Cash Position | 217,852 | 70,435 | 40,022 | 41,041 | 56,475 |
| Net Cash Flow | $161,377 | $13,960 | $-16,453 | $-15,434 | $-43,773 |
| Free Cash Flow | |||||
| Operating Cash Flow | -85,618 | -70,091 | -42,269 | -12,368 | -130,901 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -326 |
| Free Cash Flow | -85,618 | -70,091 | -42,269 | -12,368 | -131,227 |